Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.

Saved in:
Bibliographic Details
Title: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Authors: Horak P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Heining C; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Kreutzfeldt S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Hutter B; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Mock A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany., Hüllein J; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Fröhlich M; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Uhrig S; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Jahn A; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Rump A; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Gieldon L; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Möhrmann L; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Hanf D; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Teleanu V; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Heilig CE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Lipka DB; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Allgäuer M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Ruhnke L; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Laßmann A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Endris V; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Neumann O; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Penzel R; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Beck K; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Richter D; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Winter U; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Wolf S; German Cancer Consortium (DKTK), Heidelberg, Germany.; High-Throughput Sequencing Unit, Genomics and Proteomics Core Facility, DKFZ, Heidelberg, Germany., Pfütze K; German Cancer Consortium (DKTK), Heidelberg, Germany.; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Geörg C; German Cancer Consortium (DKTK), Heidelberg, Germany.; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Meißburger B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Buchhalter I; Omics IT and Data Management Core Facility, DKFZ, Heidelberg, Germany., Augustin M; Department of Hematology and Oncology, Klinikum Nuremberg, Paracelsus Medical University, Nuremberg, Germany., Aulitzky WE; Department of Hematology, Oncology and Palliative Medicine, Robert Bosch Hospital, Stuttgart, Germany., Hohenberger P; Sarcoma Unit, Interdisciplinary Tumor Center Mannheim, Mannheim University Medical Center, Heidelberg University, Mannheim, Germany.; Department of Surgery, Mannheim University Medical Center, Heidelberg University, Mannheim, Germany., Kroiss M; Department of Medicine I, Würzburg University Hospital, Würzburg, Germany.; Comprehensive Cancer Mainfranken, University of Würzburg, Würzburg, Germany.; Department of Medicine IV, University Hospital, Ludwig Maximilians University Munich, Munich, Germany., Schirmacher P; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Schlenk RF; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany., Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; DKTK, Berlin, Germany., Klauschen F; DKTK, Berlin, Germany.; Institute of Pathology, Charité - Universitätsmedizin Berlin, and Berlin Institute of Health, Berlin, Germany., Folprecht G; DKTK, Dresden, Germany.; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Bauer S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; DKTK, Essen, Germany., Siveke JT; DKTK, Essen, Germany.; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, DKTK, Essen, and DKFZ, Heidelberg, Germany., Brandts CH; University Cancer Center (UCT) Frankfurt, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; Frankfurt Cancer Institute, Frankfurt, Germany.; DKTK, Frankfurt, Germany., Kindler T; UCT Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.; DKTK, Mainz, Germany., Boerries M; Comprehensive Cancer Center Freiburg, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; DKTK, Freiburg, Germany., Illert AL; Comprehensive Cancer Center Freiburg, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; DKTK, Freiburg, Germany.; Department of Internal Medicine I, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., von Bubnoff N; Department of Internal Medicine I, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany., Jost PJ; Department of Hematology and Oncology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.; Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria.; DKTK, Munich, Germany., Spiekermann K; DKTK, Munich, Germany.; Department of Medicine III, University Hospital, Ludwig Maximilians University Munich, Munich, Germany., Bitzer M; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; DKTK, Tübingen, Germany., Schulze-Osthoff K; DKTK, Tübingen, Germany.; Department of Molecular Medicine, Interfaculty Institute for Biochemistry, University of Tübingen, Tübingen, Germany., von Kalle C; Clinical Study Center, Charité - Universitätsmedizin Berlin, and Berlin Institute of Health, Berlin, Germany., Klink B; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; National Center of Genetics, Laboratoire National de Santé, Dudelange, Luxembourg.; Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Brors B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Stenzinger A; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Schröck E; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Hübschmann D; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany., Weichert W; DKTK, Munich, Germany.; Institute of Pathology, Technical University Munich, Munich, Germany., Glimm H; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany. stefan.froehling@nct-heidelberg.de hanno.glimm@nct-dresden.de.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Fröhling S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany. stefan.froehling@nct-heidelberg.de hanno.glimm@nct-dresden.de.; German Cancer Consortium (DKTK), Heidelberg, Germany.
Source: Cancer discovery [Cancer Discov] 2021 Nov; Vol. 11 (11), pp. 2780-2795. Date of Electronic Publication: 2021 Jun 10.
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-21-0126